1. Home
  2. STKL vs ANAB Comparison

STKL vs ANAB Comparison

Compare STKL & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • ANAB
  • Stock Information
  • Founded
  • STKL 1973
  • ANAB 2005
  • Country
  • STKL United States
  • ANAB United States
  • Employees
  • STKL N/A
  • ANAB N/A
  • Industry
  • STKL Precious Metals
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKL Basic Materials
  • ANAB Health Care
  • Exchange
  • STKL Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • STKL 694.7M
  • ANAB 621.1M
  • IPO Year
  • STKL N/A
  • ANAB 2017
  • Fundamental
  • Price
  • STKL $6.26
  • ANAB $26.55
  • Analyst Decision
  • STKL Strong Buy
  • ANAB Buy
  • Analyst Count
  • STKL 2
  • ANAB 10
  • Target Price
  • STKL $9.50
  • ANAB $44.25
  • AVG Volume (30 Days)
  • STKL 803.4K
  • ANAB 499.6K
  • Earning Date
  • STKL 08-06-2025
  • ANAB 08-04-2025
  • Dividend Yield
  • STKL N/A
  • ANAB N/A
  • EPS Growth
  • STKL N/A
  • ANAB N/A
  • EPS
  • STKL N/A
  • ANAB N/A
  • Revenue
  • STKL $740,934,000.00
  • ANAB $111,872,000.00
  • Revenue This Year
  • STKL $10.78
  • ANAB N/A
  • Revenue Next Year
  • STKL $8.39
  • ANAB $24.39
  • P/E Ratio
  • STKL N/A
  • ANAB N/A
  • Revenue Growth
  • STKL 12.92
  • ANAB 387.20
  • 52 Week Low
  • STKL $3.65
  • ANAB $12.21
  • 52 Week High
  • STKL $8.11
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • STKL 56.23
  • ANAB 70.24
  • Support Level
  • STKL $6.15
  • ANAB $23.10
  • Resistance Level
  • STKL $6.66
  • ANAB $26.17
  • Average True Range (ATR)
  • STKL 0.28
  • ANAB 1.33
  • MACD
  • STKL 0.03
  • ANAB 0.27
  • Stochastic Oscillator
  • STKL 56.99
  • ANAB 100.00

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: